로딩 중…
지수 로딩 중…
SG HealthCare Co., Ltd.
398120· KOSDAQ· Health Care· Health Care Equipment & Services
₩2,050+0.49%
2026-11-02
Financials
Valuation Metrics
SG HealthCare Co., Ltd.'s Market Cap is ₩243B. At end of 2025 it was ₩355B. Ranked #2159 of 2,411 in KR market (top 90%), #1402 of 1,632 on KOSDAQ (top 86%), #88 of 94 in Health Care Equipment & Services (top 94%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 24.28B KRW | KR#2,159/2,411 Sec#88/94 |
| Revenue | 25.96B KRW | KR#2,077/2,411 Sec#70/94 |
| Net Income | 1.06B KRW | KR#1,475/2,411 Sec#48/94 |
| Total Assets | 38.56B KRW | KR#2,285/2,411 Sec#81/94 |
| Net Assets | 25.16B KRW | KR#2,219/2,411 Sec#82/94 |
| Employees | 35 | KR#2,161/2,411 Sec#84/94 |
| Value | ||
| P/E | 22.92x | KR#1,250/2,411 Sec#40/94 |
| P/B | 0.96x | KR#1,521/2,411 Sec#42/94 |
| P/S | 0.94x | KR#1,396/2,411 Sec#24/94 |
| EV/EBITDA | 16.68x | KR#963/2,411 Sec#32/94 |
| Profitability | ||
| ROE | 4.21% | KR#1,191/2,411 Sec#40/94 |
| ROA | 2.75% | KR#1,084/2,411 Sec#41/94 |
| Op. Margin | 6.21% | KR#809/2,411 Sec#36/94 |
| Revenue Growth | 52.76% | KR#191/2,411 Sec#12/94 |
| Financial Health | ||
| Debt Ratio | 53.26% | KR#1,002/2,411 Sec#58/94 |
| Total Debt | 7.51B KRW | KR#1,702/2,411 Sec#53/94 |
| Cash | 4.89B KRW | KR#2,005/2,411 Sec#69/94 |
| Current Ratio | 1.94x | KR#896/2,411 Sec#52/94 |
| Net Debt/EBITDA | 1.63x | KR#802/2,411 Sec#33/94 |
| Performance | ||
| 1Y Return | -29.55% | KR#1,435/2,411 Sec#44/94 |
| 1M Return | -9.49% | KR#323/2,411 Sec#15/94 |
| From 52W High | -58.54% | KR#1,580/2,411 Sec#55/94 |
| 1Y MDD | -62.80% | KR#1,614/2,411 Sec#57/94 |
| Trading | ||
| Volume | 5,116 shares | KR#1,583/2,411 Sec#62/94 |
| Trading Value | 10.4M KRW | KR#1,836/2,411 Sec#76/94 |
| Foreign Own. | 2.99% | KR#1,294/2,411 Sec#44/94 |
| Per Share | ||
| EPS | 89 KRW | KR#1,446/2,411 Sec#45/94 |
| BPS | 2,125 KRW | KR#2,054/2,411 Sec#67/94 |
Company Info
SG Healthcare, established in 2009, specializes in the manufacturing and sales of medical imaging diagnostic devices, listing on KOSDAQ in 2024. The company produces X-ray, C-arm, CT/MRI, and ultrasound equipment. In 2021, it established a subsidiary to develop AI software, receiving approval in 2022. SG Healthcare is expanding R&D investments in medical imaging diagnostic devices and AI software, growing into a specialized medical device company headquartered in Icheon-si, Gyeonggi-do.